Fulcrum Therapeutics Ownership | Who Owns Fulcrum Therapeutics?

Overview ForecastFinancials Chart Transcripts

Fulcrum Therapeutics Ownership Summary

Fulcrum Therapeutics is owned by 104.81% institutional investors, 3.35% insiders. Suvretta capital management is the largest institutional shareholder, holding 10.36% of FULC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.43% of its assets in Fulcrum Therapeutics shares.

FULC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Fulcrum Therapeutics	104.81%	3.35%	-8.15%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Suvretta capital management	6.56M	10.36%	$50.32M
Blackrock funding, inc. /de	5.39M	8.51%	$41.35M
Blackrock	4.80M	7.74%	$29.75M
Vanguard group	3.56M	5.69%	$40.26M
Nantahala capital management	3.05M	4.81%	$23.39M
Point72 asset management	2.07M	3.27%	$15.91M
Gsk	1.79M	2.82%	$13.70M
Balyasny asset management	1.78M	2.81%	$13.65M
D. e. shaw	1.62M	2.56%	$12.45M
State street	1.55M	2.45%	$11.89M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Mass general brigham	205.36K	6.20%	$1.27M
Allostery investments lp	40.35K	3.54%	$277.63K
Gsk	1.79M	2.29%	$13.70M
Suvretta capital management	6.56M	1.29%	$50.32M
Nantahala capital management	3.05M	0.86%	$23.39M
Logos global management lp	1.50M	0.75%	$9.30M
Ikarian capital	1.05M	0.65%	$8.05M
Acuta capital partners	57.14K	0.54%	$525.70K
Adar1 capital management	341.61K	0.30%	$3.14M
Pharvision advisers	23.87K	0.12%	$219.59K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	4.80M	0.00%	3.26M
Assenagon asset management	1.19M	0.01%	1.19M
Blackrock funding, inc. /de	5.39M	0.00%	1.13M
Balyasny asset management	1.78M	0.02%	809.51K
Qube research	974.74K	0.01%	582.25K

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-6.05M
Rtw investments, lp	-	-	-5.85M
Tcg crossover management	-	-	-5.25M
Braidwell lp	-	-	-3.13M
Cowen and company	-	-	-2.96M

New Positions

Holder	Shares	% Assets	Change	Value
Assenagon asset management	1.19M	0.01%	1.19M	$9.16M
Vanguard fiduciary trust	329.88K	0.00%	329.88K	$2.53M
Panagora asset management	243.56K	0.01%	243.56K	$1.87M
Two sigma investments, lp	139.00K	0.00%	139.00K	$1.07M
Engineers gate manager lp	126.11K	0.01%	126.11K	$967.26K

Sold Out

Holder	Change
Hughes financial services	-1.00
Newedge advisors	-3.00
Clearstead advisors	-4.00
Root financial partners	-14.00
Jpl wealth management	-17.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	163	-6.86%	79,929,975	11.45%	104	1.18%	101	-8.18%	37	-5.13%
Mar 31, 2026	165	-6.78%	71,360,421	5.81%	112	0.97%	104	4.00%	37	-27.45%
Dec 31, 2025	31	-76.69%	5,744,707	-89.33%	9	0.12%	15	-77.61%	9	-78.57%
Sep 30, 2025	41	-68.22%	4,755,539	-91.26%	7	0.10%	18	-68.97%	11	-76.60%
Jun 30, 2025	128	7.56%	54,400,559	5.91%	86	1.29%	58	23.40%	46	4.55%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.85M	3.43%	-
Vanguard MStar Total Stk Mkt Idx Invest	2.07M	3.12%	-
Vanguard Total Stock Mkt Idx Inv	2.07M	3.11%	-
Vanguard Morn Total Stk Mkt Idx Investor	2.07M	2.72%	-
abrdn Life Sciences Investors	1.61M	2.41%	90.09K
Fidelity Growth Compy Commingled Pl O	1.35M	2.16%	-464.60K
BlackRock Advantage Small Cap Core Instl	1.42M	2.14%	100.03K
iShares Russell 2000 ETF	1.52M	1.99%	-26.98K
Fidelity Select Biotechnology	1.14M	1.83%	-111.80K
abrdn Healthcare Investors	877.11K	1.32%	183.66K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 16, 2026	TANG KEVIN	-	Buy	$415.35K
Jul 17, 2026	TANG KEVIN	-	Buy	$179.33K
Jul 14, 2026	TANG KEVIN	-	Buy	$271.91K
Jul 14, 2026	TANG KEVIN	-	Buy	$191.00K
Jul 15, 2026	TANG KEVIN	-	Buy	$382.26K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	4	-
2026 Q2	-	1
2026 Q1	-	3
2025 Q4	-	5
2025 Q2	-	1

FULC Ownership FAQ

Who Owns Fulcrum Therapeutics?

Fulcrum Therapeutics shareholders are primarily institutional investors at 104.81%, followed by 3.35% insiders and -8.16% retail investors. The average institutional ownership in Fulcrum Therapeutics's industry, Biotech Stocks , is 379.61%, which Fulcrum Therapeutics falls below.

Who owns the most shares of Fulcrum Therapeutics?

Fulcrum Therapeutics’s largest shareholders are Suvretta capital management (6.56M shares, 10.36%), Blackrock funding, inc. /de (5.39M shares, 8.51%), and Blackrock (4.8M shares, 7.74%). Together, they hold 26.61% of Fulcrum Therapeutics’s total shares outstanding.

Does Blackrock own Fulcrum Therapeutics?

Yes, BlackRock owns 7.74% of Fulcrum Therapeutics, totaling 4.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.75M$. In the last quarter, BlackRock increased its holdings by 3.26M shares, a 211.35% change.

Who is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested?

Mass general brigham is Fulcrum Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.20% of its assets in 205.36K Fulcrum Therapeutics shares, valued at 1.27M$.

Who is the top mutual fund holder of Fulcrum Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fulcrum Therapeutics shares, with 3.43% of its total shares outstanding invested in 1.85M Fulcrum Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools